tirzepatide pulled from market FDA reconsidering its decision to take off its drug shortage list Tirzepatide Market Trends, Share and

Liquid creep is considered

New facilities take even longer to come online, and on top of that, more than 40% of key starting materials used for U.S.-approved active ingredients are sourced from China, introducing geopolitical and logistical risks

Oral glutathione is also not listed as part of the Asian-Pacific Association for the Study of the Liver clinical practice guidelines for the management and treatment of NAFLD

While it introduces a new mechanism of action, the committee opted to place it on formulary as a Non-Preferred Brand with a New-to-Market Block, allowing time to assess comparative effectiveness and member response